Susceptibility testing of tulathromycin: Interpretative breakpoints and susceptibility of field isolates

Veterinary Microbiology

Volumn 129, Issue 3-4, 2008, Pages 426-432

  Godinho, K S ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Antibacterial; Bovine and porcine isolates; Susceptibility testing

Indexed keywords

TULATHROMYCIN;

ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SENSITIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CATTLE DISEASES; DISACCHARIDES; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; EUROPE; HAEMOPHILUS SOMNUS; HETEROCYCLIC COMPOUNDS; HYDROGEN-ION CONCENTRATION; MANNHEIMIA HAEMOLYTICA; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA BOVIS; MYCOPLASMA HYOPNEUMONIAE; PASTEURELLA MULTOCIDA; RESPIRATORY TRACT INFECTIONS; SWINE; SWINE DISEASES;

BOVINAE; SUS;

EID: 43049179389     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2007.11.033     Document Type: Article

References (12)

1. CLSI-Clinical and Laboratory Standards Institute, 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from farm animals; Approved Standard, second ed. CLSI (formerly National Committee of Clinical Laboratory Standards-NCCLS), 940 West Valley Road, Suite 1400, Wayne, PA 19087, USA. Doc. M31-A2.22.
2. 2. J. Antimicrob. Chemother. 41 (1998) 387-389
3. Evans N.A. Tulathromycin: an overview of a new triamilide antimicrobial for livestock respiratory disease. Vet. Ther. 6 (2005) 83-95
4. Godinho K.S., Keane S.G., Nanjiani I.A., Benchaoui H.A., Sunderland S.J., Jones M.A., Weatherley A.J., Gootz T.D., and Rowan T.G. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology. Vet. Ther. 6 (2005) 113-121
5. Godinho K.S., Rae A., Windsor G.D., Tilt N., Rowan T.G., and Sunderland S.J. Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young diary calves. Vet. Ther. 6 (2005) 96-112
6. Kaspar H., Schröer U., and Wallmann J. Quantitative resistance level (MIC) of Pasteurella multocida isolated from pigs between 2004 and 2006: National resistance monitoring by the BVL. Berl. Münch. Tierärztl. Wochenschr. 120 (2007) 442-451
7. McKelvie J., Morgan J.H., Nanjiani I.A., Sherington J., Rowan T.G., and Sunderland S.J. Evaluation of tulathromycin for the treatment of pneumonia following experimental infection of swine with Mycoplasma hyopneumoniae. Vet. Ther. 6 (2005) 197-202
8. Nanjiani I.A., McKelvie J., Benchaoui H.A., Godinho K.S., Sherington J., Sunderland S.J., Weatherley A.J., and Rowan T.G. Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe. Vet. Ther. 6 (2005) 203-213
9. Pruul H., and McDonald P.J. Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. Antimicrob. Agents Chemother. 36 (1992) 10-16
10. 2 and serum) on MIC values of tulathromycin against Haemophilus somnus. Proc. 23rd World Buiatrics Congr. (2004) 70-71
11. ® broth microdilution technique to antimicrobial susceptibility testing of Mycoplasma gallisepticum. Avian Dis. 36 (1992) 714-717
12. Wallmann J. Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals. Int. J. Med. Microbiol. 296 (2006) 81-86